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Branchio-oto-renal (BOR) syndrome is characterized by ear malformations, cervical fistulas, hearing loss, and renal
anomalies. It is an autosomal dominant disorder with variable clinical manifestations. The most common features
of BOR syndrome are branchial, hearing, and renal anomalies. However, many affected subjects have been observed
with branchial-cleft anomalies and hearing loss but without renal anomalies, a condition called “branchio-otic”
(BO) syndrome. It is logical to question whether the BOR and BO syndromes are allelic or whether they represent
distinct genetic entities. We identified a very large extended family whose members had branchial and hearing
anomalies associated with commissural lip pits that segregated in an autosomal dominant fashion. Using a ge-
nomewide search strategy, we identified genetic linkage, with a maximum LOD score of 4.81 at recombination
fraction 0, between the BO phenotype and polymorphic marker D1S2757 in the genetic region of chromosome
1q31. This is the first report of linkage for a second gene associated with BOR syndrome. The findings have
important clinical implications and will provide insight into the genetic basis of BOR syndrome.
Branchio-oto-renal (BOR [MIM 113650]) syndrome is
a developmental disorder characterized by branchial
cleft cysts, renal anomalies, hearing loss, and other oto-
logic manifestations. It is an autosomal dominant dis-
order, with ear pits, branchial clefts, and hearing anom-
alies being the symptoms that are expressed most
frequently. The association between ear anomalies and
cervical fistula was first described in the late 19th century
(Asherson 1834; Heusinger 1864; Paget 1878). How-
ever, the syndrome was not well recognized until the
publication of the genetic mode of inheritance of bran-
chial and hearing anomalies (Precechtel 1927; Fourman
and Fourman 1955). Since then, several other research-
ers have published reports about BOR syndrome, and
more-precise clinical definition has emerged (Fraser et
al. 1978; Melnick et al. 1978; Cremers and Fikkers-Van
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Noord 1980). Many other clinical features—such as ab-
normalities of the face, palate, ureters, and bladder, dys-
function of the lacrimal system, otitis media, and shoul-
der abnormalities—have also been associated with BOR
syndrome (Fitch and Srolovitz 1976; Cremers and Fik-
kers-Van Noord 1980; Preisch et al. 1985; Heimler and
Lieber 1986; Pennie and Marres 1992). However, the
issue of genetic heterogeneity associated with clinical
variations such as branchio-otic (BO), branchio-renal
(BR), branchio-oculo-urethral (Fraser et al. 1983), and
branchio-oculo-facial (McCool and Weaver 1994; Lin
et al. 1995) syndromes, remains unresolved.
The incidence of BOR syndrome is ∼1:40,000 and has
been reported to occur in 2% of profoundly deaf chil-
dren (Fraser et al. 1980). The first BOR syndrome gene
has been mapped to chromosome 8q (Kumar et al. 1992,
1996; Smith et al. 1992); recently, the EYA1 gene (ho-
mologous to the Drosophila developmental gene de-
noted as “eyes absent”) underlying this syndrome has
been identified, and several mutations have been re-
ported (Abdelhak et al. 1997; Kumar et al. 1998a,
1998b). The clinical expression of the BOR-syndrome
gene is extremely variable from one family to the next
Figure 1 Genotypic data for 1q markers, listed in centromere-to-telomere order, for the kindred with BO. Haplotype results that are associated with affected status are indicated by a red bar.
The genotypes shown in parentheses are inferred from their children.
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Figure 2 Ideogram of chromosome 1. The genetic distance be-
tween markers is presented, and the approximate location of the BO
gene is indicated by a vertical bar.
Table 1
Two-Point LOD Scores of Different Polymorphic
Markers on Chromosome 1q, for BO Syndrome
MARKER
LOD SCORE AT v =a
.0 .05 .1 .2 .3 .4
D1S2815 2` -.95 -.03 .55 .56 .29
D1S218 2` -1.15 -.58 -.10 .05 .07
D1S2640 2` 2.58 2.53 2.07 1.40 .60
D1S238 1.28 1.16 1.04 .79 .52 .26
D1S461 1.87 1.88 1.74 1.31 .78 .25
D1S422 3.91 3.58 3.23 2.46 1.62 .70
D1S2877 .65 .58 .51 .36 .22 .10
D1S2654 3.59 3.28 2.95 2.47 1.46 .61
D1S2757 4.81 4.41 3.99 3.08 2.06 .94
D1S1660 1.42 1.30 1.17 .91 .63 .32
D1S2622 2` 3.13 3.04 2.48 1.69 .76
D1S1723 4.81 4.41 3.99 3.08 2.06 .94
D1S2665 3.59 3.28 2.95 2.24 1.46 .61
D1S2668 1.20 1.09 .97 .72 .46 .20
D1S249 2` 1.85 2.08 1.87 1.32 .60
a v values for males were assumed to be equal to those
for females.
(Fraser et al. 1978; Melnick et al. 1978; Cremers and
Fikkers-Van Noord 1980; Heimler and Lieber 1986).
Clinical studies suggest that there are at least three
distinct syndromes involved in the branchiogenic dis-
orders: the first, BOR dysplasia, is associated with renal
anomalies; but the second, BO dysplasia, lacks renal
anomalies; and the third, BR anomalies, results in bran-
chial and renal disorders with no associated hearing loss.
The question arises as to whether BOR syndrome, BO,
and BR are due to (a) different alleles at the same locus,
(b) mutations at totally separate loci, or (c) “normal”
variation in a highly diverse phenotype.
Identification of a second genetic locus associated with
BOR syndrome would provide important understanding
about the spectrum of defects associated with branchial
and hearing anomalies. The familial disorder described
in the present study resembles the clinical phenotypes of
BOR syndrome. We have identified a very large family
in whose members affected with BO the disease gene
segregates in an autosomal dominant fashion, with no
evidence of linkage to markers in the chromosome 8q
region (Kumar et al. 1998c). As a part of ongoing study,
the purpose of the present investigation was to identify
the genetic locus in this family, by linkage, as a first step
toward identification of the gene defect responsible for
BO. Conclusive evidence of genetic linkage with markers
on chromosome 1q31 was obtained, establishing a ge-
netic heterogeneity associated with BOR syndrome.
A multigenerational BO family was identified when
the proband visited the clinic at the University Hospital
Nijmegen, The Netherlands. Subsequently, several fam-
ily members were contacted, and blood samples were
collected. A total of 55 individuals, consisting of 32 male
subjects, 7 of whom had BO, and 23 female subjects, 8
of whom have BO, were studied in this large family. The
family members are scattered throughout The Nether-
lands; they have been consistent in undergoing medical
investigation or treatment. Recently, <35 individuals
have undergone clinical evaluation at a hospital in The
Netherlands. All individuals received a clinical exami-
nation, which included general medical and detailed oto-
rhino-laryngological evaluations. Pure-tone audiometry
was performed on all persons of age 13.5 years. If this
consistently showed conductive or mixed hearing loss,
an impedance test also was performed. Renal exami-
nation included analysis of blood and urine chemistry,
renal ultrasonography, and intravenous pyelography.
The details of clinical evaluation have been described
elsewhere (Marres et al. 1994).
There is a high degree of variability in the phenotypic
expression of BOR syndrome, observed both among pa-
tients with both typical (classic) and among those with
atypical manifestations. This is observed both within
and between families. In typical BOR syndrome, many
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Figure 3 Multipoint analysis. Multipoint LOD scores observed
between the BO phenotype and markers on the chromosome 1q31
region are presented on the X-axis, and the positions of markers loci
are located on the Y-axis. The order of markers and the genetic v used
in the analyses are as in figure 1.
organs are involved, and there are branchial, hearing,
and renal anomalies, whereas an atypical case might
include involvement of only one or a few organs (Fraser
et al. 1978, 1980; Melnick et al. 1978), such as in the
case of BO or BR. The reduced penetrance associated
with BOR syndrome might pose a problem in linkage
analysis. Therefore, our criteria for inclusion of affected
individuals in the analysis were very stringent, to avoid
any spurious linkage. The disease in affected members
of this family is characterized by ear anomalies, preauric-
ular sinuses, deafness, and commissural lip pits.
For purposes of linkage analysis, individuals with two
or more of these major findings were considered to be
affected. People with only one component of the disorder
were characterized as “unknown.” Members who did
not undergo clinical evaluation also were characterized
as being of “unknown” status. All people who had mar-
ried into the family were assumed to be unaffected. The
analysis was performed with full penetrance, as well as
with 0.8-adjusted penetrance. Phenotypically, affected
members of the family had the branchial and otic ab-
normalities typical of BO syndrome, with the addition
of commissural lip pits. After localization of the BOR-
syndrome gene on chromosome 8q, we investigated
members of this family by use of 8q markers and did
not find cosegregation with either the BO phenotype
or mutations in the EYA1 gene (Kumar et al. 1998c).
This result indicates that BO syndrome is not allelic to
BOR syndrome. Both the portion of the pedigree rele-
vant to genetic-linkage study and the haplotype data are
shown in figure 1.
Fluorescently labeled microsatellite markers from all
27 panels of the ABI Prism Linkage mapping set, version
1, were typed for the family members with BO. These
panels span all of the chromosomes, with a ∼10-cM
resolution between markers. Additional markers were
also obtained from Integrated DNA Technologies, to re-
fine the BOR2 region. Resulting genotype data were an-
alyzed by use of GENESCAN 2.1 and GENOTYPER
2.0 software from ABI. Linkage analysis was performed
on a personal computer using the LINKAGE computer
package, version 5.1. Two-point linkage analysis was
performed by use of FASTLINK, version 3.0 (Cot-
tingham et al. 1993), and the multipoint analysis was
done by use of the memory-efficient computer program
VITESSE (O’Connell and Weeks 1995). LOD scores
were calculated by use of a model of an autosomal dom-
inant mode of inheritance. The marker-allele frequency
was assumed to be uniformly distributed. Distances be-
tween markers are shown in figure 2.
With use of ABI panel markers, a genomewide search
was performed on the selected informative individuals
in the family. Initial linkage analysis with ABI panel
markers yielded a maximum two-point LOD score of
1.2, at recombination fraction (v) .05, for marker
D1S249. More family members were then included in
the next analysis, to increase the linkage information.
Several other neighboring markers also were genotyped.
A linkage with a maximum LOD score of 4.8, for marker
D1S2757, was then observed. This establishes the pres-
ence of a second genetic locus associated with BOR syn-
drome; henceforth, it will be referred to as “BOR2.”
Once the linkage was established, a high-density map of
additional closely spaced markers was obtained from the
human-genome database for the BOR2 critical region.
Two-point LOD scores, calculated under an autosomal
dominant model, for several markers spanning the can-
didate interval region are summarized in table 1.
We repeated the multipoint analysis of the critical re-
gion, using 15 polymorphic markers. Map distances
used in the analysis are presented in figure 1. The anal-
ysis was done by use of two penetrance models. Under
the model of reduced penetrance (with a penetrance of
.8), the maximum LOD score of 4.32 was observed be-
tween markers D1S2654 and D1S2757, whereas the full-
penetrance model yielded a maximum LOD score
of 4.91 at a position between markers D1S2757 and
D1S1660. The results of the multipoint analysis suggest
that the likely location of the BO gene is within the 23.6-
cM interval between D1S2640 and D1S2668 (fig. 3). In
light of the marker haplotype segregating with BO (fig.
2), it can be seen that a critical recombination event that
limits the assignment of BO to the region distal to
D1S2640 was observed in individual II-16. The pedigree
also displays crossover in individual III-20, limiting the
assignment of BO to a position proximal to D1S249.
Individual 35 in generation III provides provisional data,
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analysis of which suggests that the gene might be prox-
imal to D1S2622. This conclusion must be considered
tentative, because of the problem regarding penetrance
in this family. Individual III-38 is not included in the
analysis, since the clinical data were inconclusive.
The 1q31 region is known to contain the locus for
van der Woude syndrome (VWS), a highly penetrant
craniofacial disorder with an autosomal dominant mode
of inheritance. VWS maps (1q32-41) close to the BOR2
region and is characterized by lip pits, clefting of the
primary or secondary palate, and hypodontia. Since, in
the family that we studied, several members with BO
had commissural lip pits, we decided to investigate the
1q31 region, for any possible relationship. Markers
D1S2692, D1S245, D1S505, D1S419, and D1S2629
have been mapped to the region of VWS (Sander et al.
1995). Therefore, in the family under study, we have
typed this marker in the members with BO. The two-
point result suggests that the BO gene is not within the
VWS region.
In the present analysis, only individuals who had dis-
tinctive clinical features (i.e., presence of more than one
clinical phenotype) were included in the analysis; for
example, family members 15 and 34 in generation II and
family members 18 and 37 in generation III (fig. 2) had
only one clinical phenotype, and these individuals were
excluded from the linkage analysis, to avoid any spu-
rious results in the initial screening process. However, it
is interesting to note that individual 4 in generation IV
has only commissural lip pits, which we initially con-
sidered to be one of the clinical features strongly indic-
ative of this syndrome. Clearly, this individual did not
inherit from his parents the affected segment of chro-
mosome 1. This result suggests that, in members of this
family, the commissural lip pits are perhaps not asso-
ciated with BO and are segregating independent of this
syndrome. Further studies will be needed to confirm this
possibility.
In this report, we have presented evidence of a second
genetic locus for BO syndrome. Linkage was performed
by use of two different models, one with a reduced pen-
etrance level and the other with complete penetrance.
Both models gave essentially similar results and dem-
onstrated evidence that a gene in this region of chro-
mosome 1q is involved in the etiology of branchial and
hearing anomalies. The genetic-linkage analysis was lim-
ited to this large, multigenerational family. Indeed, we
have a large data set of families, both large and small,
whose members have BOR syndrome. Since there is a
great deal of clinical variability associated with BOR
syndrome, it is quite possible that several genes are in-
volved in this developmental disorder, and it is difficult
to evaluate the possibility of linkage in members of the
smaller families. Therefore, our first attempt was to
screen all families for mutations in the EYA1 gene, to
determine the proportion of families without linkage to
the chromosome 8q region. Surprisingly, ∼70% of our
large data set of families whose members have BOR
syndrome do not show mutations in the EYA1 gene (Ku-
mar et al. 1998a, 1998b). This further complicates the
issue and suggests either that most of the mutations lie
in the untranslated region or that several genes are in-
volved in the branchiogenic disorder. At present, it is
difficult to evaluate what percentage of families will have
linkage to 1q or 8q, since most of the families were not
sufficiently large to give conclusive evidence of linkage.
However, identification of the second gene will help re-
solve this issue. Given the fact that the BOR syndrome
phenotype is highly heterogeneous and that other fam-
ilies with BO have been shown not to have linkage to
the 8q region (Stratakis et al. 1998), it is possible that
there is a third responsible locus in branchiogenic
disorders.
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